Global Drug Discovery Outsourcing Market Insights, Growth, Share & Size: By Workflow, By Therapeutic Area, By Drug Type, By End-Users, By Region & Segmental Forecast, 2023 – 2031, Comparative Analysis and Trends
Global Drug Discovery Outsourcing Market was Valued at USD 3.6 Billion in 2022, with a 7.79% CAGR (2023 – 2031): Absolute Markets Insights
Drug discovery is a complex and resource-intensive process that involves identifying and developing new medications. Outsourcing in drug discovery refers to the practice of partnering with external organizations, such as contract research organizations (CROs) or academic institutions, to perform certain stages or aspects of the drug discovery process. This practice is often employed by pharmaceutical companies and biotechnology firms to leverage specialized expertise, increase efficiency, and reduce costs.
Global Drug Discovery Outsourcing Market Trends
The unusual diminution of large pharmaceuticals' internal discovery, patent expiration, and shift towards biologics have resulted in an increase in externalization and outsourcing operations. With limited resources, the sector is seeking for new sources of discovery and innovation, and there is a rising inclination for externalization and willingness to accept the notion of outsourcing. Although pharmaceutical firms have traditionally outsourced part of their tasks, drug discovery research outsourcing has increased dramatically in the previous ten years. A significant increase in global communications, the ability to access expertise outside of big pharma, and a growing number of signatories to Trade Related Aspects of Intellectual Property Rights (TRIPS) are among the supporting aspects for the growth of the global drug discovery outsourcing market.
Global Drug Discovery Outsourcing Market Revenue & Forecast, (US$ Million), 2015 – 2031
Drug discovery outsourcing for biology services is on the rise due to a combination of factors that are shaping the pharmaceutical and biotechnology industries. This trend reflects a strategic approach to leverage external expertise and resources in order to enhance the efficiency and success of drug discovery efforts, particularly in the biological aspects of the process. Moreover, partnering with specialized CROs is expediting the drug discovery process by streamlining various biological assays and tests. This can lead to faster development timelines and cost savings, as CROs are equipped to handle specific tasks efficiently. Thus, the biologics segment in the global drug discovery outsourcing market is anticipated to be the fastest growing segment during the forecast period 2023-2031.
Outsourcing is being supported by the growth of biologics research and orphan medications, breakthrough technical platforms, and shifting business models in pharma and biotech. Despite the fact that big pharma is shifting its focus to research institutes and universities in order to expedite knowledge and exploit innovation and technological platforms, it lacks the infrastructure to transfer pharmaceuticals from the early phases of drug development. These reasons will likely boost the drug discovery outsourcing market in the approaching years.
In 2022, North America held the largest share of the drug discovery outsourcing market. The United States has a strong biopharmaceutical industry and are looking forward to tap into specialized expertise that may not be available in-house. Many CROs in the United States are equipped with state-of-the-art technologies and infrastructure for various stages of drug discovery, such as target identification, hit validation, and lead optimization which is supporting the growth of the market. Moreover, due to the presence of the leading market players such as Charles River Laboratories, QIAGEN, Thermo Fisher Scientific Inc. in United States and Canada is supporting the faster growth of the drug discovery outsourcing market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global drug discovery outsourcing market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global drug discovery outsourcing market are:
- Charles River Laboratories
- Domainex
- Eurofins DiscoverX Products
- EVOTEC SE
- GenScript
- Jubilant Biosys Ltd
- Laboratory Corporation of America Holdings
- Oncodesign
- Pharmaron
- QIAGEN
- Sygnature Discovery
- Syngene International Ltd.
- Thermo Fisher Scientific Inc.
- WuXi AppTec
- Other market participants
Global Drug Discovery Outsourcing Market
By Workflow
- Target Identification & Screening
- Target Validation & Functional Informatics
- Lead Optimization & Candidate Identification
- Preclinical Development
- Others
By Therapeutics Area
- Respiratory
- Pain and Anesthesia
- Oncology
- Ophthalmology
- Hematology
- Cardiovascular
- Endocrine
- Gastrointestinal
- Immunomodulation
- Anti-infective
- Central Nervous System
- Dermatology
- Genitourinary System
- Others
By Drug Type
- Small Molecules
- Large Molecules
By Service Type
- Chemistry Services
- Biology Services
By End-users
- Pharmaceutical & Biotechnology companies
- Academic Institutes
- Research Organizations
- Others
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 – 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Drug Discovery Outsourcing Market
6. Market Synopsis: Drug
Discovery Outsourcing Market
7. Drug Discovery Outsourcing Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Drug Discovery Outsourcing Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Drug Discovery Outsourcing Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Drug Discovery Outsourcing Market
8. Global Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
8.1. Overview
8.1.1. Global
Drug Discovery Outsourcing Market Revenue (US$ Mn)
8.2. Global
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Workflow
8.2.1. Target Identification
and Screening
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2022
8.2.1.3. Market Forecast, 2023 - 2031
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 - 2022
8.2.1.5.1.2. Market
Forecast, 2023 - 2031
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2022
8.2.1.5.2.2. Market
Forecast, 2023 - 2031
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2022
8.2.1.5.3.2. Market
Forecast, 2023 - 2031
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2022
8.2.1.5.4.2. Market
Forecast, 2023 - 2031
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 - 2022
8.2.1.5.5.2. Market
Forecast, 2023 - 2031
8.2.2. Target
Validation and Functional Informatics
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.2.3. Lead
Optimization and Candidate Identification
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2022
8.2.3.3. Market Forecast, 2023 - 2031
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 - 2022
8.2.3.5.1.2. Market
Forecast, 2023 - 2031
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2022
8.2.3.5.2.2. Market
Forecast, 2023 - 2031
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2022
8.2.3.5.3.2. Market
Forecast, 2023 - 2031
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2022
8.2.3.5.4.2. Market
Forecast, 2023 - 2031
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 - 2022
8.2.3.5.5.2. Market
Forecast, 2023 - 2031
8.2.4. Preclinical
Development
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2022
8.2.4.3. Market Forecast, 2023 - 2031
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 - 2022
8.2.4.5.1.2. Market
Forecast, 2023 - 2031
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2022
8.2.4.5.2.2. Market
Forecast, 2023 - 2031
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2022
8.2.4.5.3.2. Market
Forecast, 2023 - 2031
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2022
8.2.4.5.4.2. Market
Forecast, 2023 - 2031
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 - 2022
8.2.4.5.5.2. Market
Forecast, 2023 - 2031
8.2.5. Others
8.2.5.1. Definition
8.2.5.2. Market Estimation and Penetration, 2015 - 2022
8.2.5.3. Market Forecast, 2023 - 2031
8.2.5.4. Compound Annual Growth Rate (CAGR)
8.2.5.5. Regional Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 - 2022
8.2.5.5.1.2. Market
Forecast, 2023 - 2031
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 - 2022
8.2.5.5.2.2. Market
Forecast, 2023 - 2031
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 - 2022
8.2.5.5.3.2. Market
Forecast, 2023 - 2031
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 - 2022
8.2.5.5.4.2. Market
Forecast, 2023 - 2031
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 - 2022
8.2.5.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By Workflow
9. Global Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
9.1. Overview
9.2. Global
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
9.2.1. Respiratory
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2. Pain and
Anesthesia
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.2.3. Oncology
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 - 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 - 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 - 2031
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 - 2031
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 - 2031
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 - 2031
9.2.4. Ophthalmology
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2022
9.2.4.3. Market Forecast, 2023 - 2031
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2022
9.2.4.5.1.2. Market
Forecast, 2023 - 2031
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2022
9.2.4.5.2.2. Market
Forecast, 2023 - 2031
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2022
9.2.4.5.3.2. Market
Forecast, 2023 - 2031
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2022
9.2.4.5.4.2. Market
Forecast, 2023 - 2031
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2022
9.2.4.5.5.2. Market
Forecast, 2023 - 2031
9.2.5. Hematology
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2022
9.2.5.3. Market Forecast, 2023 - 2031
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 - 2022
9.2.5.5.1.2. Market
Forecast, 2023 - 2031
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2022
9.2.5.5.2.2. Market
Forecast, 2023 - 2031
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2022
9.2.5.5.3.2. Market
Forecast, 2023 - 2031
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2022
9.2.5.5.4.2. Market
Forecast, 2023 - 2031
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 - 2022
9.2.5.5.5.2. Market
Forecast, 2023 - 2031
9.2.6. Cardiovascular
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2022
9.2.6.3. Market Forecast, 2023 - 2031
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2015 - 2022
9.2.6.5.1.2. Market
Forecast, 2023 - 2031
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2022
9.2.6.5.2.2. Market
Forecast, 2023 - 2031
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2022
9.2.6.5.3.2. Market
Forecast, 2023 - 2031
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2022
9.2.6.5.4.2. Market
Forecast, 2023 - 2031
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2015 - 2022
9.2.6.5.5.2. Market
Forecast, 2023 - 2031
9.2.7. Endocrine
9.2.7.1. Definition
9.2.7.2. Market Estimation and Penetration, 2015 - 2022
9.2.7.3. Market Forecast, 2023 - 2031
9.2.7.4. Compound Annual Growth Rate (CAGR)
9.2.7.5. Regional Bifurcation
9.2.7.5.1. North
America
9.2.7.5.1.1. Market
Estimation, 2015 - 2022
9.2.7.5.1.2. Market
Forecast, 2023 - 2031
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2022
9.2.7.5.2.2. Market
Forecast, 2023 - 2031
9.2.7.5.3. Asia
Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2022
9.2.7.5.3.2. Market
Forecast, 2023 - 2031
9.2.7.5.4. Middle
East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2022
9.2.7.5.4.2. Market
Forecast, 2023 - 2031
9.2.7.5.5. Latin
America
9.2.7.5.5.1. Market
Estimation, 2015 - 2022
9.2.7.5.5.2. Market
Forecast, 2023 - 2031
9.2.8. Gastrointestinal
9.2.8.1. Definition
9.2.8.2. Market Estimation and Penetration, 2015 - 2022
9.2.8.3. Market Forecast, 2023 - 2031
9.2.8.4. Compound Annual Growth Rate (CAGR)
9.2.8.5. Regional Bifurcation
9.2.8.5.1. North
America
9.2.8.5.1.1. Market
Estimation, 2015 - 2022
9.2.8.5.1.2. Market
Forecast, 2023 - 2031
9.2.8.5.2. Europe
9.2.8.5.2.1. Market
Estimation, 2015 - 2022
9.2.8.5.2.2. Market
Forecast, 2023 - 2031
9.2.8.5.3. Asia
Pacific
9.2.8.5.3.1. Market
Estimation, 2015 - 2022
9.2.8.5.3.2. Market
Forecast, 2023 - 2031
9.2.8.5.4. Middle
East and Africa
9.2.8.5.4.1. Market
Estimation, 2015 - 2022
9.2.8.5.4.2. Market
Forecast, 2023 - 2031
9.2.8.5.5. Latin
America
9.2.8.5.5.1. Market
Estimation, 2015 - 2022
9.2.8.5.5.2. Market
Forecast, 2023 - 2031
9.2.9. Immunomodulation
9.2.9.1. Definition
9.2.9.2. Market Estimation and Penetration, 2015 - 2022
9.2.9.3. Market Forecast, 2023 - 2031
9.2.9.4. Compound Annual Growth Rate (CAGR)
9.2.9.5. Regional Bifurcation
9.2.9.5.1. North
America
9.2.9.5.1.1. Market
Estimation, 2015 - 2022
9.2.9.5.1.2. Market
Forecast, 2023 - 2031
9.2.9.5.2. Europe
9.2.9.5.2.1. Market
Estimation, 2015 - 2022
9.2.9.5.2.2. Market
Forecast, 2023 - 2031
9.2.9.5.3. Asia
Pacific
9.2.9.5.3.1. Market
Estimation, 2015 - 2022
9.2.9.5.3.2. Market
Forecast, 2023 - 2031
9.2.9.5.4. Middle
East and Africa
9.2.9.5.4.1. Market
Estimation, 2015 - 2022
9.2.9.5.4.2. Market
Forecast, 2023 - 2031
9.2.9.5.5. Latin
America
9.2.9.5.5.1. Market
Estimation, 2015 - 2022
9.2.9.5.5.2. Market
Forecast, 2023 - 2031
9.2.10. Anti-infective
9.2.10.1. Definition
9.2.10.2. Market Estimation and Penetration, 2015 - 2022
9.2.10.3. Market Forecast, 2023 - 2031
9.2.10.4. Compound Annual Growth Rate (CAGR)
9.2.10.5. Regional Bifurcation
9.2.10.5.1. North
America
9.2.10.5.1.1. Market
Estimation, 2015 - 2022
9.2.10.5.1.2. Market
Forecast, 2023 - 2031
9.2.10.5.2. Europe
9.2.10.5.2.1. Market
Estimation, 2015 - 2022
9.2.10.5.2.2. Market
Forecast, 2023 - 2031
9.2.10.5.3. Asia
Pacific
9.2.10.5.3.1. Market
Estimation, 2015 - 2022
9.2.10.5.3.2. Market
Forecast, 2023 - 2031
9.2.10.5.4. Middle
East and Africa
9.2.10.5.4.1. Market
Estimation, 2015 - 2022
9.2.10.5.4.2. Market
Forecast, 2023 - 2031
9.2.10.5.5. Latin
America
9.2.10.5.5.1. Market
Estimation, 2015 - 2022
9.2.10.5.5.2. Market
Forecast, 2023 - 2031
9.2.11. Central
Nervous System
9.2.11.1. Definition
9.2.11.2. Market Estimation and Penetration, 2015 - 2022
9.2.11.3. Market Forecast, 2023 - 2031
9.2.11.4. Compound Annual Growth Rate (CAGR)
9.2.11.5. Regional Bifurcation
9.2.11.5.1. North
America
9.2.11.5.1.1. Market
Estimation, 2015 - 2022
9.2.11.5.1.2. Market
Forecast, 2023 - 2031
9.2.11.5.2. Europe
9.2.11.5.2.1. Market
Estimation, 2015 - 2022
9.2.11.5.2.2. Market
Forecast, 2023 - 2031
9.2.11.5.3. Asia
Pacific
9.2.11.5.3.1. Market
Estimation, 2015 - 2022
9.2.11.5.3.2. Market
Forecast, 2023 - 2031
9.2.11.5.4. Middle
East and Africa
9.2.11.5.4.1. Market
Estimation, 2015 - 2022
9.2.11.5.4.2. Market
Forecast, 2023 - 2031
9.2.11.5.5. Latin
America
9.2.11.5.5.1. Market
Estimation, 2015 - 2022
9.2.11.5.5.2. Market
Forecast, 2023 - 2031
9.2.12. Dermatology
9.2.12.1. Definition
9.2.12.2. Market Estimation and Penetration, 2015 - 2022
9.2.12.3. Market Forecast, 2023 - 2031
9.2.12.4. Compound Annual Growth Rate (CAGR)
9.2.12.5. Regional Bifurcation
9.2.12.5.1. North
America
9.2.12.5.1.1. Market
Estimation, 2015 - 2022
9.2.12.5.1.2. Market
Forecast, 2023 - 2031
9.2.12.5.2. Europe
9.2.12.5.2.1. Market
Estimation, 2015 - 2022
9.2.12.5.2.2. Market
Forecast, 2023 - 2031
9.2.12.5.3. Asia
Pacific
9.2.12.5.3.1. Market
Estimation, 2015 - 2022
9.2.12.5.3.2. Market
Forecast, 2023 - 2031
9.2.12.5.4. Middle
East and Africa
9.2.12.5.4.1. Market
Estimation, 2015 - 2022
9.2.12.5.4.2. Market
Forecast, 2023 - 2031
9.2.12.5.5. Latin
America
9.2.12.5.5.1. Market
Estimation, 2015 - 2022
9.2.12.5.5.2. Market
Forecast, 2023 - 2031
9.2.13. Genitourinary
System
9.2.13.1. Definition
9.2.13.2. Market Estimation and Penetration, 2015 - 2022
9.2.13.3. Market Forecast, 2023 - 2031
9.2.13.4. Compound Annual Growth Rate (CAGR)
9.2.13.5. Regional Bifurcation
9.2.13.5.1. North
America
9.2.13.5.1.1. Market
Estimation, 2015 - 2022
9.2.13.5.1.2. Market
Forecast, 2023 - 2031
9.2.13.5.2. Europe
9.2.13.5.2.1. Market
Estimation, 2015 - 2022
9.2.13.5.2.2. Market
Forecast, 2023 - 2031
9.2.13.5.3. Asia
Pacific
9.2.13.5.3.1. Market
Estimation, 2015 - 2022
9.2.13.5.3.2. Market
Forecast, 2023 - 2031
9.2.13.5.4. Middle
East and Africa
9.2.13.5.4.1. Market
Estimation, 2015 - 2022
9.2.13.5.4.2. Market
Forecast, 2023 - 2031
9.2.13.5.5. Latin
America
9.2.13.5.5.1. Market
Estimation, 2015 - 2022
9.2.13.5.5.2. Market
Forecast, 2023 - 2031
9.2.14. Others
9.2.14.1. Definition
9.2.14.2. Market Estimation and Penetration, 2015 - 2022
9.2.14.3. Market Forecast, 2023 - 2031
9.2.14.4. Compound Annual Growth Rate (CAGR)
9.2.14.5. Regional Bifurcation
9.2.14.5.1. North
America
9.2.14.5.1.1. Market
Estimation, 2015 - 2022
9.2.14.5.1.2. Market
Forecast, 2023 - 2031
9.2.14.5.2. Europe
9.2.14.5.2.1. Market
Estimation, 2015 - 2022
9.2.14.5.2.2. Market
Forecast, 2023 - 2031
9.2.14.5.3. Asia
Pacific
9.2.14.5.3.1. Market
Estimation, 2015 - 2022
9.2.14.5.3.2. Market
Forecast, 2023 - 2031
9.2.14.5.4. Middle
East and Africa
9.2.14.5.4.1. Market
Estimation, 2015 - 2022
9.2.14.5.4.2. Market
Forecast, 2023 - 2031
9.2.14.5.5. Latin
America
9.2.14.5.5.1. Market
Estimation, 2015 - 2022
9.2.14.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By
Therapeutic Area
10. Global Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
10.1. Overview
10.2. Global
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Drug Type
10.2.1. Small
Molecules
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Large
Molecules
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By Drug
Type
11. Global Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
11.1. Overview
11.2. Global
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Service
Type
11.2.1. Chemistry
Services
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2. Biology
Services
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By
Service Type
12. Global Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
12.1. Overview
12.2. Global
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By End-users
12.2.1. Pharmaceutical
and Biotechnology companies
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2022
12.2.1.3. Market Forecast, 2023 - 2031
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 - 2022
12.2.1.5.1.2. Market
Forecast, 2023 - 2031
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2022
12.2.1.5.2.2. Market
Forecast, 2023 - 2031
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2022
12.2.1.5.3.2. Market
Forecast, 2023 - 2031
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2022
12.2.1.5.4.2. Market
Forecast, 2023 - 2031
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 - 2022
12.2.1.5.5.2. Market
Forecast, 2023 - 2031
12.2.2. Academic
Institutes
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2022
12.2.2.3. Market Forecast, 2023 - 2031
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 - 2022
12.2.2.5.1.2. Market
Forecast, 2023 - 2031
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2022
12.2.2.5.2.2. Market
Forecast, 2023 - 2031
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2022
12.2.2.5.3.2. Market
Forecast, 2023 - 2031
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2022
12.2.2.5.4.2. Market
Forecast, 2023 - 2031
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 - 2022
12.2.2.5.5.2. Market
Forecast, 2023 - 2031
12.2.3. Research
Organizations
12.2.3.1. Definition
12.2.3.2. Market Estimation and Penetration, 2015 - 2022
12.2.3.3. Market Forecast, 2023 - 2031
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North
America
12.2.3.5.1.1. Market
Estimation, 2015 - 2022
12.2.3.5.1.2. Market
Forecast, 2023 - 2031
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 - 2022
12.2.3.5.2.2. Market
Forecast, 2023 - 2031
12.2.3.5.3. Asia
Pacific
12.2.3.5.3.1. Market
Estimation, 2015 - 2022
12.2.3.5.3.2. Market
Forecast, 2023 - 2031
12.2.3.5.4. Middle
East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 - 2022
12.2.3.5.4.2. Market
Forecast, 2023 - 2031
12.2.3.5.5. Latin
America
12.2.3.5.5.1. Market
Estimation, 2015 - 2022
12.2.3.5.5.2. Market
Forecast, 2023 - 2031
12.2.4. Others
12.2.4.1. Definition
12.2.4.2. Market Estimation and Penetration, 2015 - 2022
12.2.4.3. Market Forecast, 2023 - 2031
12.2.4.4. Compound Annual Growth Rate (CAGR)
12.2.4.5. Regional Bifurcation
12.2.4.5.1. North
America
12.2.4.5.1.1. Market
Estimation, 2015 - 2022
12.2.4.5.1.2. Market
Forecast, 2023 - 2031
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 - 2022
12.2.4.5.2.2. Market
Forecast, 2023 - 2031
12.2.4.5.3. Asia
Pacific
12.2.4.5.3.1. Market
Estimation, 2015 - 2022
12.2.4.5.3.2. Market
Forecast, 2023 - 2031
12.2.4.5.4. Middle
East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 - 2022
12.2.4.5.4.2. Market
Forecast, 2023 - 2031
12.2.4.5.5. Latin
America
12.2.4.5.5.1. Market
Estimation, 2015 - 2022
12.2.4.5.5.2. Market
Forecast, 2023 - 2031
12.3. Key
Segment for Channeling Investments
12.3.1. By
End-users
13. North America Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
13.1. Overview
13.1.1. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn)
13.2. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Workflow
13.2.1. Target
Identification and Screening
13.2.2. Target
Validation and Functional Informatics
13.2.3. Lead
Optimization and Candidate Identification
13.2.4. Preclinical
Development
13.2.5. Others
13.3. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
13.3.1. Respiratory
13.3.2. Pain
and Anesthesia
13.3.3. Oncology
13.3.4. Ophthalmology
13.3.5. Hematology
13.3.6. Cardiovascular
13.3.7. Endocrine
13.3.8. Gastrointestinal
13.3.9. Immunomodulation
13.3.10. Anti-infective
13.3.11. Central
Nervous System
13.3.12. Dermatology
13.3.13. Genitourinary
System
13.3.14. Others
13.4. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Drug Type
13.4.1. Small
Molecules
13.4.2. Large
Molecules
13.5. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Service Type
13.5.1. Chemistry
Services
13.5.2. Biology
Services
13.6. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
End-users
13.6.1. Pharmaceutical
and Biotechnology companies
13.6.2. Academic
Institutes
13.6.3. Research
Organizations
13.6.4. Others
13.7. North
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Country
13.7.1. U.S
13.7.1.1. U.S Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.7.1.1.1. Target
Identification and Screening
13.7.1.1.2. Target
Validation and Functional Informatics
13.7.1.1.3. Lead
Optimization and Candidate Identification
13.7.1.1.4. Preclinical
Development
13.7.1.1.5. Others
13.7.1.2. U.S Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
13.7.1.2.1. Respiratory
13.7.1.2.2. Pain
and Anesthesia
13.7.1.2.3. Oncology
13.7.1.2.4. Ophthalmology
13.7.1.2.5. Hematology
13.7.1.2.6. Cardiovascular
13.7.1.2.7. Endocrine
13.7.1.2.8. Gastrointestinal
13.7.1.2.9. Immunomodulation
13.7.1.2.10. Anti-infective
13.7.1.2.11. Central
Nervous System
13.7.1.2.12. Dermatology
13.7.1.2.13. Genitourinary
System
13.7.1.2.14. Others
13.7.1.3. U.S Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
13.7.1.3.1. Small
Molecules
13.7.1.3.2. Large
Molecules
13.7.1.4. U.S Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.7.1.4.1. Chemistry
Services
13.7.1.4.2. Biology
Services
13.7.1.5. U.S Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
13.7.1.5.1. Pharmaceutical
and Biotechnology companies
13.7.1.5.2. Academic
Institutes
13.7.1.5.3. Research
Organizations
13.7.1.5.4. Others
13.7.2. Canada
13.7.2.1. Canada Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.7.2.1.1. Target
Identification and Screening
13.7.2.1.2. Target
Validation and Functional Informatics
13.7.2.1.3. Lead
Optimization and Candidate Identification
13.7.2.1.4. Preclinical
Development
13.7.2.1.5. Others
13.7.2.2. Canada Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
13.7.2.2.1. Respiratory
13.7.2.2.2. Pain
and Anesthesia
13.7.2.2.3. Oncology
13.7.2.2.4. Ophthalmology
13.7.2.2.5. Hematology
13.7.2.2.6. Cardiovascular
13.7.2.2.7. Endocrine
13.7.2.2.8. Gastrointestinal
13.7.2.2.9. Immunomodulation
13.7.2.2.10. Anti-infective
13.7.2.2.11. Central
Nervous System
13.7.2.2.12. Dermatology
13.7.2.2.13. Genitourinary
System
13.7.2.2.14. Others
13.7.2.3. Canada Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
13.7.2.3.1. Small
Molecules
13.7.2.3.2. Large
Molecules
13.7.2.4. Canada Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.7.2.4.1. Chemistry
Services
13.7.2.4.2. Biology
Services
13.7.2.5. Canada Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
13.7.2.5.1. Pharmaceutical
and Biotechnology companies
13.7.2.5.2. Academic
Institutes
13.7.2.5.3. Research
Organizations
13.7.2.5.4. Others
13.7.3. Mexico
13.7.3.1. Mexico Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.7.3.1.1. Target
Identification and Screening
13.7.3.1.2. Target
Validation and Functional Informatics
13.7.3.1.3. Lead
Optimization and Candidate Identification
13.7.3.1.4. Preclinical
Development
13.7.3.1.5. Others
13.7.3.2. Mexico Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
13.7.3.2.1. Respiratory
13.7.3.2.2. Pain
and Anesthesia
13.7.3.2.3. Oncology
13.7.3.2.4. Ophthalmology
13.7.3.2.5. Hematology
13.7.3.2.6. Cardiovascular
13.7.3.2.7. Endocrine
13.7.3.2.8. Gastrointestinal
13.7.3.2.9. Immunomodulation
13.7.3.2.10. Anti-infective
13.7.3.2.11. Central
Nervous System
13.7.3.2.12. Dermatology
13.7.3.2.13. Genitourinary
System
13.7.3.2.14. Others
13.7.3.3. Mexico Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
13.7.3.3.1. Small
Molecules
13.7.3.3.2. Large
Molecules
13.7.3.4. Mexico Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.7.3.4.1. Chemistry
Services
13.7.3.4.2. Biology
Services
13.7.3.5. Mexico Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
13.7.3.5.1. Pharmaceutical
and Biotechnology companies
13.7.3.5.2. Academic
Institutes
13.7.3.5.3. Research
Organizations
13.7.3.5.4. Others
13.7.4. Rest of
North America
13.7.4.1. Rest of North America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Workflow
13.7.4.1.1. Target
Identification and Screening
13.7.4.1.2. Target
Validation and Functional Informatics
13.7.4.1.3. Lead
Optimization and Candidate Identification
13.7.4.1.4. Preclinical
Development
13.7.4.1.5. Others
13.7.4.2. Rest of North America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.7.4.2.1. Respiratory
13.7.4.2.2. Pain
and Anesthesia
13.7.4.2.3. Oncology
13.7.4.2.4. Ophthalmology
13.7.4.2.5. Hematology
13.7.4.2.6. Cardiovascular
13.7.4.2.7. Endocrine
13.7.4.2.8. Gastrointestinal
13.7.4.2.9. Immunomodulation
13.7.4.2.10. Anti-infective
13.7.4.2.11. Central
Nervous System
13.7.4.2.12. Dermatology
13.7.4.2.13. Genitourinary
System
13.7.4.2.14. Others
13.7.4.3. Rest of North America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Drug Type
13.7.4.3.1. Small
Molecules
13.7.4.3.2. Large
Molecules
13.7.4.4. Rest of North America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Service Type
13.7.4.4.1. Chemistry
Services
13.7.4.4.2. Biology
Services
13.7.4.5. Rest of North America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By End-users
13.7.4.5.1. Pharmaceutical
and Biotechnology companies
13.7.4.5.2. Academic
Institutes
13.7.4.5.3. Research
Organizations
13.7.4.5.4. Others
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Workflow
13.8.3. By
Therapeutic Area
13.8.4. By Drug
Type
13.8.5. By
Service Type
13.8.6. By
End-users
14. Europe Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
14.1. Overview
14.1.1. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn)
14.2. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Workflow
14.2.1. Target
Identification and Screening
14.2.2. Target
Validation and Functional Informatics
14.2.3. Lead
Optimization and Candidate Identification
14.2.4. Preclinical
Development
14.2.5. Others
14.3. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
14.3.1. Respiratory
14.3.2. Pain
and Anesthesia
14.3.3. Oncology
14.3.4. Ophthalmology
14.3.5. Hematology
14.3.6. Cardiovascular
14.3.7. Endocrine
14.3.8. Gastrointestinal
14.3.9. Immunomodulation
14.3.10. Anti-infective
14.3.11. Central
Nervous System
14.3.12. Dermatology
14.3.13. Genitourinary
System
14.3.14. Others
14.4. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.4.1. Small
Molecules
14.4.2. Large
Molecules
14.5. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Service
Type
14.5.1. Chemistry
Services
14.5.2. Biology
Services
14.6. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By End-users
14.6.1. Pharmaceutical
and Biotechnology companies
14.6.2. Academic
Institutes
14.6.3. Research
Organizations
14.6.4. Others
14.7. Europe
Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.7.1.1.1. Target
Identification and Screening
14.7.1.1.2. Target
Validation and Functional Informatics
14.7.1.1.3. Lead
Optimization and Candidate Identification
14.7.1.1.4. Preclinical
Development
14.7.1.1.5. Others
14.7.1.2. France Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
14.7.1.2.1. Respiratory
14.7.1.2.2. Pain
and Anesthesia
14.7.1.2.3. Oncology
14.7.1.2.4. Ophthalmology
14.7.1.2.5. Hematology
14.7.1.2.6. Cardiovascular
14.7.1.2.7. Endocrine
14.7.1.2.8. Gastrointestinal
14.7.1.2.9. Immunomodulation
14.7.1.2.10. Anti-infective
14.7.1.2.11. Central
Nervous System
14.7.1.2.12. Dermatology
14.7.1.2.13. Genitourinary
System
14.7.1.2.14. Others
14.7.1.3. France Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
14.7.1.3.1. Small
Molecules
14.7.1.3.2. Large
Molecules
14.7.1.4. France Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.7.1.4.1. Chemistry
Services
14.7.1.4.2. Biology
Services
14.7.1.5. France Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
14.7.1.5.1. Pharmaceutical
and Biotechnology companies
14.7.1.5.2. Academic
Institutes
14.7.1.5.3. Research
Organizations
14.7.1.5.4. Others
14.7.2. The UK
14.7.2.1. The UK Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.7.2.1.1. Target
Identification and Screening
14.7.2.1.2. Target
Validation and Functional Informatics
14.7.2.1.3. Lead
Optimization and Candidate Identification
14.7.2.1.4. Preclinical
Development
14.7.2.1.5. Others
14.7.2.2. The UK Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
14.7.2.2.1. Respiratory
14.7.2.2.2. Pain
and Anesthesia
14.7.2.2.3. Oncology
14.7.2.2.4. Ophthalmology
14.7.2.2.5. Hematology
14.7.2.2.6. Cardiovascular
14.7.2.2.7. Endocrine
14.7.2.2.8. Gastrointestinal
14.7.2.2.9. Immunomodulation
14.7.2.2.10. Anti-infective
14.7.2.2.11. Central
Nervous System
14.7.2.2.12. Dermatology
14.7.2.2.13. Genitourinary
System
14.7.2.2.14. Others
14.7.2.3. The UK Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
14.7.2.3.1. Small
Molecules
14.7.2.3.2. Large
Molecules
14.7.2.4. The UK Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.7.2.4.1. Chemistry
Services
14.7.2.4.2. Biology
Services
14.7.2.5. The UK Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
14.7.2.5.1. Pharmaceutical
and Biotechnology companies
14.7.2.5.2. Academic
Institutes
14.7.2.5.3. Research
Organizations
14.7.2.5.4. Others
14.7.3. Spain
14.7.3.1. Spain Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.7.3.1.1. Target
Identification and Screening
14.7.3.1.2. Target
Validation and Functional Informatics
14.7.3.1.3. Lead
Optimization and Candidate Identification
14.7.3.1.4. Preclinical
Development
14.7.3.1.5. Others
14.7.3.2. Spain Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
14.7.3.2.1. Respiratory
14.7.3.2.2. Pain
and Anesthesia
14.7.3.2.3. Oncology
14.7.3.2.4. Ophthalmology
14.7.3.2.5. Hematology
14.7.3.2.6. Cardiovascular
14.7.3.2.7. Endocrine
14.7.3.2.8. Gastrointestinal
14.7.3.2.9. Immunomodulation
14.7.3.2.10. Anti-infective
14.7.3.2.11. Central
Nervous System
14.7.3.2.12. Dermatology
14.7.3.2.13. Genitourinary
System
14.7.3.2.14. Others
14.7.3.3. Spain Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
14.7.3.3.1. Small
Molecules
14.7.3.3.2. Large
Molecules
14.7.3.4. Spain Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.7.3.4.1. Chemistry
Services
14.7.3.4.2. Biology
Services
14.7.3.5. Spain Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
14.7.3.5.1. Pharmaceutical
and Biotechnology companies
14.7.3.5.2. Academic
Institutes
14.7.3.5.3. Research
Organizations
14.7.3.5.4. Others
14.7.4. Germany
14.7.4.1. Germany Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.7.4.1.1. Target
Identification and Screening
14.7.4.1.2. Target
Validation and Functional Informatics
14.7.4.1.3. Lead
Optimization and Candidate Identification
14.7.4.1.4. Preclinical
Development
14.7.4.1.5. Others
14.7.4.2. Germany Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
14.7.4.2.1. Respiratory
14.7.4.2.2. Pain
and Anesthesia
14.7.4.2.3. Oncology
14.7.4.2.4. Ophthalmology
14.7.4.2.5. Hematology
14.7.4.2.6. Cardiovascular
14.7.4.2.7. Endocrine
14.7.4.2.8. Gastrointestinal
14.7.4.2.9. Immunomodulation
14.7.4.2.10. Anti-infective
14.7.4.2.11. Central
Nervous System
14.7.4.2.12. Dermatology
14.7.4.2.13. Genitourinary
System
14.7.4.2.14. Others
14.7.4.3. Germany Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
14.7.4.3.1. Small
Molecules
14.7.4.3.2. Large
Molecules
14.7.4.4. Germany Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.7.4.4.1. Chemistry
Services
14.7.4.4.2. Biology
Services
14.7.4.5. Germany Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
14.7.4.5.1. Pharmaceutical
and Biotechnology companies
14.7.4.5.2. Academic
Institutes
14.7.4.5.3. Research
Organizations
14.7.4.5.4. Others
14.7.5. Italy
14.7.5.1. Italy Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.7.5.1.1. Target
Identification and Screening
14.7.5.1.2. Target
Validation and Functional Informatics
14.7.5.1.3. Lead
Optimization and Candidate Identification
14.7.5.1.4. Preclinical
Development
14.7.5.1.5. Others
14.7.5.2. Italy Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
14.7.5.2.1. Respiratory
14.7.5.2.2. Pain
and Anesthesia
14.7.5.2.3. Oncology
14.7.5.2.4. Ophthalmology
14.7.5.2.5. Hematology
14.7.5.2.6. Cardiovascular
14.7.5.2.7. Endocrine
14.7.5.2.8. Gastrointestinal
14.7.5.2.9. Immunomodulation
14.7.5.2.10. Anti-infective
14.7.5.2.11. Central
Nervous System
14.7.5.2.12. Dermatology
14.7.5.2.13. Genitourinary
System
14.7.5.2.14. Others
14.7.5.3. Italy Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
14.7.5.3.1. Small
Molecules
14.7.5.3.2. Large
Molecules
14.7.5.4. Italy Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.7.5.4.1. Chemistry
Services
14.7.5.4.2. Biology
Services
14.7.5.5. Italy Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
14.7.5.5.1. Pharmaceutical
and Biotechnology companies
14.7.5.5.2. Academic
Institutes
14.7.5.5.3. Research
Organizations
14.7.5.5.4. Others
14.7.6. Nordic
Countries
14.7.6.1. Nordic Countries Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Workflow
14.7.6.1.1. Target
Identification and Screening
14.7.6.1.2. Target
Validation and Functional Informatics
14.7.6.1.3. Lead
Optimization and Candidate Identification
14.7.6.1.4. Preclinical
Development
14.7.6.1.5. Others
14.7.6.2. Nordic Countries Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Therapeutic Area
14.7.6.2.1. Respiratory
14.7.6.2.2. Pain
and Anesthesia
14.7.6.2.3. Oncology
14.7.6.2.4. Ophthalmology
14.7.6.2.5. Hematology
14.7.6.2.6. Cardiovascular
14.7.6.2.7. Endocrine
14.7.6.2.8. Gastrointestinal
14.7.6.2.9. Immunomodulation
14.7.6.2.10. Anti-infective
14.7.6.2.11. Central
Nervous System
14.7.6.2.12. Dermatology
14.7.6.2.13. Genitourinary
System
14.7.6.2.14. Others
14.7.6.3. Nordic Countries Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Drug Type
14.7.6.3.1. Small
Molecules
14.7.6.3.2. Large
Molecules
14.7.6.4. Nordic Countries Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Service Type
14.7.6.4.1. Chemistry
Services
14.7.6.4.2. Biology
Services
14.7.6.5. Nordic Countries Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By End-users
14.7.6.5.1. Pharmaceutical
and Biotechnology companies
14.7.6.5.2. Academic
Institutes
14.7.6.5.3. Research
Organizations
14.7.6.5.4. Others
14.7.6.6. Nordic Countries Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux Union Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Workflow
14.7.7.1.1. Target
Identification and Screening
14.7.7.1.2. Target
Validation and Functional Informatics
14.7.7.1.3. Lead
Optimization and Candidate Identification
14.7.7.1.4. Preclinical
Development
14.7.7.1.5. Others
14.7.7.2. Benelux Union Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Therapeutic Area
14.7.7.2.1. Respiratory
14.7.7.2.2. Pain
and Anesthesia
14.7.7.2.3. Oncology
14.7.7.2.4. Ophthalmology
14.7.7.2.5. Hematology
14.7.7.2.6. Cardiovascular
14.7.7.2.7. Endocrine
14.7.7.2.8. Gastrointestinal
14.7.7.2.9. Immunomodulation
14.7.7.2.10. Anti-infective
14.7.7.2.11. Central
Nervous System
14.7.7.2.12. Dermatology
14.7.7.2.13. Genitourinary
System
14.7.7.2.14. Others
14.7.7.3. Benelux Union Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Drug Type
14.7.7.3.1. Small
Molecules
14.7.7.3.2. Large
Molecules
14.7.7.4. Benelux Union Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Service Type
14.7.7.4.1. Chemistry
Services
14.7.7.4.2. Biology
Services
14.7.7.5. Benelux Union Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By End-users
14.7.7.5.1. Pharmaceutical
and Biotechnology companies
14.7.7.5.2. Academic
Institutes
14.7.7.5.3. Research
Organizations
14.7.7.5.4. Others
14.7.7.6. Benelux Union Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest of Europe Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Workflow
14.7.8.1.1. Target
Identification and Screening
14.7.8.1.2. Target
Validation and Functional Informatics
14.7.8.1.3. Lead
Optimization and Candidate Identification
14.7.8.1.4. Preclinical
Development
14.7.8.1.5. Others
14.7.8.2. Rest of Europe Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Therapeutic Area
14.7.8.2.1. Respiratory
14.7.8.2.2. Pain
and Anesthesia
14.7.8.2.3. Oncology
14.7.8.2.4. Ophthalmology
14.7.8.2.5. Hematology
14.7.8.2.6. Cardiovascular
14.7.8.2.7. Endocrine
14.7.8.2.8. Gastrointestinal
14.7.8.2.9. Immunomodulation
14.7.8.2.10. Anti-infective
14.7.8.2.11. Central
Nervous System
14.7.8.2.12. Dermatology
14.7.8.2.13. Genitourinary
System
14.7.8.2.14. Others
14.7.8.3. Rest of Europe Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Drug Type
14.7.8.3.1. Small
Molecules
14.7.8.3.2. Large
Molecules
14.7.8.4. Rest of Europe Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Service Type
14.7.8.4.1. Chemistry
Services
14.7.8.4.2. Biology
Services
14.7.8.5. Rest of Europe Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By End-users
14.7.8.5.1. Pharmaceutical
and Biotechnology companies
14.7.8.5.2. Academic
Institutes
14.7.8.5.3. Research
Organizations
14.7.8.5.4. Others
14.8. Key Segment
for Channeling Investments
14.8.1. By
Country
14.8.2. By
Workflow
14.8.3. By
Therapeutic Area
14.8.4. By Drug
Type
14.8.5. By
Service Type
14.8.6. By
End-users
15. Asia Pacific Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
15.1. Overview
15.1.1. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn)
15.2. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Workflow
15.2.1. Target
Identification and Screening
15.2.2. Target
Validation and Functional Informatics
15.2.3. Lead
Optimization and Candidate Identification
15.2.4. Preclinical
Development
15.2.5. Others
15.3. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
15.3.1. Respiratory
15.3.2. Pain
and Anesthesia
15.3.3. Oncology
15.3.4. Ophthalmology
15.3.5. Hematology
15.3.6. Cardiovascular
15.3.7. Endocrine
15.3.8. Gastrointestinal
15.3.9. Immunomodulation
15.3.10. Anti-infective
15.3.11. Central
Nervous System
15.3.12. Dermatology
15.3.13. Genitourinary
System
15.3.14. Others
15.4. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Drug Type
15.4.1. Small
Molecules
15.4.2. Large
Molecules
15.5. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Service Type
15.5.1. Chemistry
Services
15.5.2. Biology
Services
15.6. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
End-users
15.6.1. Pharmaceutical
and Biotechnology companies
15.6.2. Academic
Institutes
15.6.3. Research
Organizations
15.6.4. Others
15.7. Asia
Pacific Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Country
15.7.1. China
15.7.1.1. China Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
15.7.1.1.1. Target
Identification and Screening
15.7.1.1.2. Target
Validation and Functional Informatics
15.7.1.1.3. Lead
Optimization and Candidate Identification
15.7.1.1.4. Preclinical
Development
15.7.1.1.5. Others
15.7.1.2. China Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
15.7.1.2.1. Respiratory
15.7.1.2.2. Pain
and Anesthesia
15.7.1.2.3. Oncology
15.7.1.2.4. Ophthalmology
15.7.1.2.5. Hematology
15.7.1.2.6. Cardiovascular
15.7.1.2.7. Endocrine
15.7.1.2.8. Gastrointestinal
15.7.1.2.9. Immunomodulation
15.7.1.2.10. Anti-infective
15.7.1.2.11. Central
Nervous System
15.7.1.2.12. Dermatology
15.7.1.2.13. Genitourinary
System
15.7.1.2.14. Others
15.7.1.3. China Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
15.7.1.3.1. Small
Molecules
15.7.1.3.2. Large
Molecules
15.7.1.4. China Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
15.7.1.4.1. Chemistry
Services
15.7.1.4.2. Biology
Services
15.7.1.5. China Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
15.7.1.5.1. Pharmaceutical
and Biotechnology companies
15.7.1.5.2. Academic
Institutes
15.7.1.5.3. Research
Organizations
15.7.1.5.4. Others
15.7.2. Japan
15.7.2.1. Japan Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
15.7.2.1.1. Target
Identification and Screening
15.7.2.1.2. Target
Validation and Functional Informatics
15.7.2.1.3. Lead
Optimization and Candidate Identification
15.7.2.1.4. Preclinical
Development
15.7.2.1.5. Others
15.7.2.2. Japan Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
15.7.2.2.1. Respiratory
15.7.2.2.2. Pain
and Anesthesia
15.7.2.2.3. Oncology
15.7.2.2.4. Ophthalmology
15.7.2.2.5. Hematology
15.7.2.2.6. Cardiovascular
15.7.2.2.7. Endocrine
15.7.2.2.8. Gastrointestinal
15.7.2.2.9. Immunomodulation
15.7.2.2.10. Anti-infective
15.7.2.2.11. Central
Nervous System
15.7.2.2.12. Dermatology
15.7.2.2.13. Genitourinary
System
15.7.2.2.14. Others
15.7.2.3. Japan Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
15.7.2.3.1. Small
Molecules
15.7.2.3.2. Large
Molecules
15.7.2.4. Japan Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
15.7.2.4.1. Chemistry
Services
15.7.2.4.2. Biology
Services
15.7.2.5. Japan Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
15.7.2.5.1. Pharmaceutical
and Biotechnology companies
15.7.2.5.2. Academic
Institutes
15.7.2.5.3. Research
Organizations
15.7.2.5.4. Others
15.7.3. India
15.7.3.1. India Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
15.7.3.1.1. Target
Identification and Screening
15.7.3.1.2. Target
Validation and Functional Informatics
15.7.3.1.3. Lead
Optimization and Candidate Identification
15.7.3.1.4. Preclinical
Development
15.7.3.1.5. Others
15.7.3.2. India Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
15.7.3.2.1. Respiratory
15.7.3.2.2. Pain
and Anesthesia
15.7.3.2.3. Oncology
15.7.3.2.4. Ophthalmology
15.7.3.2.5. Hematology
15.7.3.2.6. Cardiovascular
15.7.3.2.7. Endocrine
15.7.3.2.8. Gastrointestinal
15.7.3.2.9. Immunomodulation
15.7.3.2.10. Anti-infective
15.7.3.2.11. Central
Nervous System
15.7.3.2.12. Dermatology
15.7.3.2.13. Genitourinary
System
15.7.3.2.14. Others
15.7.3.3. India Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
15.7.3.3.1. Small
Molecules
15.7.3.3.2. Large
Molecules
15.7.3.4. India Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
15.7.3.4.1. Chemistry
Services
15.7.3.4.2. Biology
Services
15.7.3.5. India Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
15.7.3.5.1. Pharmaceutical
and Biotechnology companies
15.7.3.5.2. Academic
Institutes
15.7.3.5.3. Research
Organizations
15.7.3.5.4. Others
15.7.4. New
Zealand
15.7.4.1. New Zealand Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Workflow
15.7.4.1.1. Target
Identification and Screening
15.7.4.1.2. Target
Validation and Functional Informatics
15.7.4.1.3. Lead
Optimization and Candidate Identification
15.7.4.1.4. Preclinical
Development
15.7.4.1.5. Others
15.7.4.2. New Zealand Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Therapeutic Area
15.7.4.2.1. Respiratory
15.7.4.2.2. Pain
and Anesthesia
15.7.4.2.3. Oncology
15.7.4.2.4. Ophthalmology
15.7.4.2.5. Hematology
15.7.4.2.6. Cardiovascular
15.7.4.2.7. Endocrine
15.7.4.2.8. Gastrointestinal
15.7.4.2.9. Immunomodulation
15.7.4.2.10. Anti-infective
15.7.4.2.11. Central
Nervous System
15.7.4.2.12. Dermatology
15.7.4.2.13. Genitourinary
System
15.7.4.2.14. Others
15.7.4.3. New Zealand Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Drug Type
15.7.4.3.1. Small
Molecules
15.7.4.3.2. Large
Molecules
15.7.4.4. New Zealand Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Service Type
15.7.4.4.1. Chemistry
Services
15.7.4.4.2. Biology
Services
15.7.4.5. New Zealand Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By End-users
15.7.4.5.1. Pharmaceutical
and Biotechnology companies
15.7.4.5.2. Academic
Institutes
15.7.4.5.3. Research
Organizations
15.7.4.5.4. Others
15.7.5. Australia
15.7.5.1. Australia Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Workflow
15.7.5.1.1. Target
Identification and Screening
15.7.5.1.2. Target
Validation and Functional Informatics
15.7.5.1.3. Lead
Optimization and Candidate Identification
15.7.5.1.4. Preclinical
Development
15.7.5.1.5. Others
15.7.5.2. Australia Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Therapeutic Area
15.7.5.2.1. Respiratory
15.7.5.2.2. Pain
and Anesthesia
15.7.5.2.3. Oncology
15.7.5.2.4. Ophthalmology
15.7.5.2.5. Hematology
15.7.5.2.6. Cardiovascular
15.7.5.2.7. Endocrine
15.7.5.2.8. Gastrointestinal
15.7.5.2.9. Immunomodulation
15.7.5.2.10. Anti-infective
15.7.5.2.11. Central
Nervous System
15.7.5.2.12. Dermatology
15.7.5.2.13. Genitourinary
System
15.7.5.2.14. Others
15.7.5.3. Australia Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Drug Type
15.7.5.3.1. Small
Molecules
15.7.5.3.2. Large
Molecules
15.7.5.4. Australia Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Service Type
15.7.5.4.1. Chemistry
Services
15.7.5.4.2. Biology
Services
15.7.5.5. Australia Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By End-users
15.7.5.5.1. Pharmaceutical
and Biotechnology companies
15.7.5.5.2. Academic
Institutes
15.7.5.5.3. Research
Organizations
15.7.5.5.4. Others
15.7.6. South
Korea
15.7.6.1. South Korea Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Workflow
15.7.6.1.1. Target
Identification and Screening
15.7.6.1.2. Target
Validation and Functional Informatics
15.7.6.1.3. Lead
Optimization and Candidate Identification
15.7.6.1.4. Preclinical
Development
15.7.6.1.5. Others
15.7.6.2. South Korea Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Therapeutic Area
15.7.6.2.1. Respiratory
15.7.6.2.2. Pain
and Anesthesia
15.7.6.2.3. Oncology
15.7.6.2.4. Ophthalmology
15.7.6.2.5. Hematology
15.7.6.2.6. Cardiovascular
15.7.6.2.7. Endocrine
15.7.6.2.8. Gastrointestinal
15.7.6.2.9. Immunomodulation
15.7.6.2.10. Anti-infective
15.7.6.2.11. Central
Nervous System
15.7.6.2.12. Dermatology
15.7.6.2.13. Genitourinary
System
15.7.6.2.14. Others
15.7.6.3. South Korea Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Drug Type
15.7.6.3.1. Small
Molecules
15.7.6.3.2. Large
Molecules
15.7.6.4. South Korea Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Service Type
15.7.6.4.1. Chemistry
Services
15.7.6.4.2. Biology
Services
15.7.6.5. South Korea Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By End-users
15.7.6.5.1. Pharmaceutical
and Biotechnology companies
15.7.6.5.2. Academic
Institutes
15.7.6.5.3. Research
Organizations
15.7.6.5.4. Others
15.7.7. Southeast
Asia
15.7.7.1. Southeast Asia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Workflow
15.7.7.1.1. Target
Identification and Screening
15.7.7.1.2. Target
Validation and Functional Informatics
15.7.7.1.3. Lead
Optimization and Candidate Identification
15.7.7.1.4. Preclinical
Development
15.7.7.1.5. Others
15.7.7.2. Southeast Asia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Therapeutic Area
15.7.7.2.1. Respiratory
15.7.7.2.2. Pain
and Anesthesia
15.7.7.2.3. Oncology
15.7.7.2.4. Ophthalmology
15.7.7.2.5. Hematology
15.7.7.2.6. Cardiovascular
15.7.7.2.7. Endocrine
15.7.7.2.8. Gastrointestinal
15.7.7.2.9. Immunomodulation
15.7.7.2.10. Anti-infective
15.7.7.2.11. Central
Nervous System
15.7.7.2.12. Dermatology
15.7.7.2.13. Genitourinary
System
15.7.7.2.14. Others
15.7.7.3. Southeast Asia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Drug Type
15.7.7.3.1. Small
Molecules
15.7.7.3.2. Large
Molecules
15.7.7.4. Southeast Asia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Service Type
15.7.7.4.1. Chemistry
Services
15.7.7.4.2. Biology
Services
15.7.7.5. Southeast Asia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By End-users
15.7.7.5.1. Pharmaceutical
and Biotechnology companies
15.7.7.5.2. Academic
Institutes
15.7.7.5.3. Research
Organizations
15.7.7.5.4. Others
15.7.7.6. Southeast Asia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest of Asia Pacific Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Workflow
15.7.8.1.1. Target
Identification and Screening
15.7.8.1.2. Target
Validation and Functional Informatics
15.7.8.1.3. Lead
Optimization and Candidate Identification
15.7.8.1.4. Preclinical
Development
15.7.8.1.5. Others
15.7.8.2. Rest of Asia Pacific Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Therapeutic Area
15.7.8.2.1. Respiratory
15.7.8.2.2. Pain
and Anesthesia
15.7.8.2.3. Oncology
15.7.8.2.4. Ophthalmology
15.7.8.2.5. Hematology
15.7.8.2.6. Cardiovascular
15.7.8.2.7. Endocrine
15.7.8.2.8. Gastrointestinal
15.7.8.2.9. Immunomodulation
15.7.8.2.10. Anti-infective
15.7.8.2.11. Central
Nervous System
15.7.8.2.12. Dermatology
15.7.8.2.13. Genitourinary
System
15.7.8.2.14. Others
15.7.8.3. Rest of Asia Pacific Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Drug Type
15.7.8.3.1. Small
Molecules
15.7.8.3.2. Large
Molecules
15.7.8.4. Rest of Asia Pacific Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Service Type
15.7.8.4.1. Chemistry
Services
15.7.8.4.2. Biology
Services
15.7.8.5. Rest of Asia Pacific Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By End-users
15.7.8.5.1. Pharmaceutical
and Biotechnology companies
15.7.8.5.2. Academic
Institutes
15.7.8.5.3. Research
Organizations
15.7.8.5.4. Others
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By
Workflow
15.8.3. By
Therapeutic Area
15.8.4. By Drug
Type
15.8.5. By
Service Type
15.8.6. By
End-users
16. Middle East and Africa Drug Discovery Outsourcing Market
Analysis and Forecasts, 2023 – 2031
16.1. Overview
16.1.1. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn)
16.2. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
16.2.1. Target
Identification and Screening
16.2.2. Target
Validation and Functional Informatics
16.2.3. Lead
Optimization and Candidate Identification
16.2.4. Preclinical
Development
16.2.5. Others
16.3. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
16.3.1. Respiratory
16.3.2. Pain
and Anesthesia
16.3.3. Oncology
16.3.4. Ophthalmology
16.3.5. Hematology
16.3.6. Cardiovascular
16.3.7. Endocrine
16.3.8. Gastrointestinal
16.3.9. Immunomodulation
16.3.10. Anti-infective
16.3.11. Central
Nervous System
16.3.12. Dermatology
16.3.13. Genitourinary
System
16.3.14. Others
16.4. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
16.4.1. Small
Molecules
16.4.2. Large
Molecules
16.5. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
16.5.1. Chemistry
Services
16.5.2. Biology
Services
16.6. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts,
By End-users
16.6.1. Pharmaceutical
and Biotechnology companies
16.6.2. Academic
Institutes
16.6.3. Research
Organizations
16.6.4. Others
16.7. Middle
East and Africa Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi Arabia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Workflow
16.7.1.1.1. Target
Identification and Screening
16.7.1.1.2. Target
Validation and Functional Informatics
16.7.1.1.3. Lead
Optimization and Candidate Identification
16.7.1.1.4. Preclinical
Development
16.7.1.1.5. Others
16.7.1.2. Saudi Arabia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Therapeutic Area
16.7.1.2.1. Respiratory
16.7.1.2.2. Pain
and Anesthesia
16.7.1.2.3. Oncology
16.7.1.2.4. Ophthalmology
16.7.1.2.5. Hematology
16.7.1.2.6. Cardiovascular
16.7.1.2.7. Endocrine
16.7.1.2.8. Gastrointestinal
16.7.1.2.9. Immunomodulation
16.7.1.2.10. Anti-infective
16.7.1.2.11. Central
Nervous System
16.7.1.2.12. Dermatology
16.7.1.2.13. Genitourinary
System
16.7.1.2.14. Others
16.7.1.3. Saudi Arabia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Drug Type
16.7.1.3.1. Small
Molecules
16.7.1.3.2. Large
Molecules
16.7.1.4. Saudi Arabia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Service Type
16.7.1.4.1. Chemistry
Services
16.7.1.4.2. Biology
Services
16.7.1.5. Saudi Arabia Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By End-users
16.7.1.5.1. Pharmaceutical
and Biotechnology companies
16.7.1.5.2. Academic
Institutes
16.7.1.5.3. Research
Organizations
16.7.1.5.4. Others
16.7.2. UAE
16.7.2.1. UAE Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
16.7.2.1.1. Target
Identification and Screening
16.7.2.1.2. Target
Validation and Functional Informatics
16.7.2.1.3. Lead
Optimization and Candidate Identification
16.7.2.1.4. Preclinical
Development
16.7.2.1.5. Others
16.7.2.2. UAE Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
16.7.2.2.1. Respiratory
16.7.2.2.2. Pain
and Anesthesia
16.7.2.2.3. Oncology
16.7.2.2.4. Ophthalmology
16.7.2.2.5. Hematology
16.7.2.2.6. Cardiovascular
16.7.2.2.7. Endocrine
16.7.2.2.8. Gastrointestinal
16.7.2.2.9. Immunomodulation
16.7.2.2.10. Anti-infective
16.7.2.2.11. Central
Nervous System
16.7.2.2.12. Dermatology
16.7.2.2.13. Genitourinary
System
16.7.2.2.14. Others
16.7.2.3. UAE Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
16.7.2.3.1. Small
Molecules
16.7.2.3.2. Large
Molecules
16.7.2.4. UAE Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
16.7.2.4.1. Chemistry
Services
16.7.2.4.2. Biology
Services
16.7.2.5. UAE Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
16.7.2.5.1. Pharmaceutical
and Biotechnology companies
16.7.2.5.2. Academic
Institutes
16.7.2.5.3. Research
Organizations
16.7.2.5.4. Others
16.7.3. Egypt
16.7.3.1. Egypt Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
16.7.3.1.1. Target
Identification and Screening
16.7.3.1.2. Target
Validation and Functional Informatics
16.7.3.1.3. Lead
Optimization and Candidate Identification
16.7.3.1.4. Preclinical
Development
16.7.3.1.5. Others
16.7.3.2. Egypt Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
16.7.3.2.1. Respiratory
16.7.3.2.2. Pain
and Anesthesia
16.7.3.2.3. Oncology
16.7.3.2.4. Ophthalmology
16.7.3.2.5. Hematology
16.7.3.2.6. Cardiovascular
16.7.3.2.7. Endocrine
16.7.3.2.8. Gastrointestinal
16.7.3.2.9. Immunomodulation
16.7.3.2.10. Anti-infective
16.7.3.2.11. Central
Nervous System
16.7.3.2.12. Dermatology
16.7.3.2.13. Genitourinary
System
16.7.3.2.14. Others
16.7.3.3. Egypt Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
16.7.3.3.1. Small
Molecules
16.7.3.3.2. Large
Molecules
16.7.3.4. Egypt Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
16.7.3.4.1. Chemistry
Services
16.7.3.4.2. Biology
Services
16.7.3.5. Egypt Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
16.7.3.5.1. Pharmaceutical
and Biotechnology companies
16.7.3.5.2. Academic
Institutes
16.7.3.5.3. Research
Organizations
16.7.3.5.4. Others
16.7.4. Kuwait
16.7.4.1. Kuwait Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
16.7.4.1.1. Target
Identification and Screening
16.7.4.1.2. Target
Validation and Functional Informatics
16.7.4.1.3. Lead
Optimization and Candidate Identification
16.7.4.1.4. Preclinical
Development
16.7.4.1.5. Others
16.7.4.2. Kuwait Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
16.7.4.2.1. Respiratory
16.7.4.2.2. Pain
and Anesthesia
16.7.4.2.3. Oncology
16.7.4.2.4. Ophthalmology
16.7.4.2.5. Hematology
16.7.4.2.6. Cardiovascular
16.7.4.2.7. Endocrine
16.7.4.2.8. Gastrointestinal
16.7.4.2.9. Immunomodulation
16.7.4.2.10. Anti-infective
16.7.4.2.11. Central
Nervous System
16.7.4.2.12. Dermatology
16.7.4.2.13. Genitourinary
System
16.7.4.2.14. Others
16.7.4.3. Kuwait Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
16.7.4.3.1. Small
Molecules
16.7.4.3.2. Large
Molecules
16.7.4.4. Kuwait Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
16.7.4.4.1. Chemistry
Services
16.7.4.4.2. Biology
Services
16.7.4.5. Kuwait Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
16.7.4.5.1. Pharmaceutical
and Biotechnology companies
16.7.4.5.2. Academic
Institutes
16.7.4.5.3. Research
Organizations
16.7.4.5.4. Others
16.7.5. South
Africa
16.7.5.1. South Africa Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Workflow
16.7.5.1.1. Target
Identification and Screening
16.7.5.1.2. Target
Validation and Functional Informatics
16.7.5.1.3. Lead
Optimization and Candidate Identification
16.7.5.1.4. Preclinical
Development
16.7.5.1.5. Others
16.7.5.2. South Africa Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Therapeutic Area
16.7.5.2.1. Respiratory
16.7.5.2.2. Pain
and Anesthesia
16.7.5.2.3. Oncology
16.7.5.2.4. Ophthalmology
16.7.5.2.5. Hematology
16.7.5.2.6. Cardiovascular
16.7.5.2.7. Endocrine
16.7.5.2.8. Gastrointestinal
16.7.5.2.9. Immunomodulation
16.7.5.2.10. Anti-infective
16.7.5.2.11. Central
Nervous System
16.7.5.2.12. Dermatology
16.7.5.2.13. Genitourinary
System
16.7.5.2.14. Others
16.7.5.3. South Africa Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Drug Type
16.7.5.3.1. Small
Molecules
16.7.5.3.2. Large
Molecules
16.7.5.4. South Africa Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By Service Type
16.7.5.4.1. Chemistry
Services
16.7.5.4.2. Biology
Services
16.7.5.5. South Africa Drug Discovery Outsourcing Market Revenue (US$
Mn) and Forecasts, By End-users
16.7.5.5.1. Pharmaceutical
and Biotechnology companies
16.7.5.5.2. Academic
Institutes
16.7.5.5.3. Research
Organizations
16.7.5.5.4. Others
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Drug Discovery Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Workflow
16.7.6.1.1. Target
Identification and Screening
16.7.6.1.2. Target
Validation and Functional Informatics
16.7.6.1.3. Lead
Optimization and Candidate Identification
16.7.6.1.4. Preclinical
Development
16.7.6.1.5. Others
16.7.6.2. Rest of Middle East & Africa Drug Discovery Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
16.7.6.2.1. Respiratory
16.7.6.2.2. Pain
and Anesthesia
16.7.6.2.3. Oncology
16.7.6.2.4. Ophthalmology
16.7.6.2.5. Hematology
16.7.6.2.6. Cardiovascular
16.7.6.2.7. Endocrine
16.7.6.2.8. Gastrointestinal
16.7.6.2.9. Immunomodulation
16.7.6.2.10. Anti-infective
16.7.6.2.11. Central
Nervous System
16.7.6.2.12. Dermatology
16.7.6.2.13. Genitourinary
System
16.7.6.2.14. Others
16.7.6.3. Rest of Middle East & Africa Drug Discovery Outsourcing
Market Revenue (US$ Mn) and Forecasts, By Drug Type
16.7.6.3.1. Small
Molecules
16.7.6.3.2. Large
Molecules
16.7.6.4. Rest of Middle East & Africa Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Service Type
16.7.6.4.1. Chemistry
Services
16.7.6.4.2. Biology
Services
16.7.6.5. Rest of Middle East & Africa Drug Discovery Outsourcing
Market Revenue (US$ Mn) and Forecasts, By End-users
16.7.6.5.1. Pharmaceutical
and Biotechnology companies
16.7.6.5.2. Academic
Institutes
16.7.6.5.3. Research
Organizations
16.7.6.5.4. Others
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Workflow
16.8.3. By
Therapeutic Area
16.8.4. By Drug
Type
16.8.5. By
Service Type
16.8.6. By
End-users
17. Latin America Drug Discovery Outsourcing Market Analysis and
Forecasts, 2023 – 2031
17.1. Overview
17.1.1. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn)
17.2. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Workflow
17.2.1. Target
Identification and Screening
17.2.2. Target
Validation and Functional Informatics
17.2.3. Lead
Optimization and Candidate Identification
17.2.4. Preclinical
Development
17.2.5. Others
17.3. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
17.3.1. Respiratory
17.3.2. Pain
and Anesthesia
17.3.3. Oncology
17.3.4. Ophthalmology
17.3.5. Hematology
17.3.6. Cardiovascular
17.3.7. Endocrine
17.3.8. Gastrointestinal
17.3.9. Immunomodulation
17.3.10. Anti-infective
17.3.11. Central
Nervous System
17.3.12. Dermatology
17.3.13. Genitourinary
System
17.3.14. Others
17.4. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Drug Type
17.4.1. Small
Molecules
17.4.2. Large
Molecules
17.5. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Service Type
17.5.1. Chemistry
Services
17.5.2. Biology
Services
17.6. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
End-users
17.6.1. Pharmaceutical
and Biotechnology companies
17.6.2. Academic
Institutes
17.6.3. Research
Organizations
17.6.4. Others
17.7. Latin
America Drug Discovery Outsourcing Market Revenue (US$ Mn) and Forecasts, By
Country
17.7.1. Brazil
17.7.1.1. Brazil Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Workflow
17.7.1.1.1. Target
Identification and Screening
17.7.1.1.2. Target
Validation and Functional Informatics
17.7.1.1.3. Lead
Optimization and Candidate Identification
17.7.1.1.4. Preclinical
Development
17.7.1.1.5. Others
17.7.1.2. Brazil Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
17.7.1.2.1. Respiratory
17.7.1.2.2. Pain
and Anesthesia
17.7.1.2.3. Oncology
17.7.1.2.4. Ophthalmology
17.7.1.2.5. Hematology
17.7.1.2.6. Cardiovascular
17.7.1.2.7. Endocrine
17.7.1.2.8. Gastrointestinal
17.7.1.2.9. Immunomodulation
17.7.1.2.10. Anti-infective
17.7.1.2.11. Central
Nervous System
17.7.1.2.12. Dermatology
17.7.1.2.13. Genitourinary
System
17.7.1.2.14. Others
17.7.1.3. Brazil Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Drug Type
17.7.1.3.1. Small
Molecules
17.7.1.3.2. Large
Molecules
17.7.1.4. Brazil Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By Service Type
17.7.1.4.1. Chemistry
Services
17.7.1.4.2. Biology
Services
17.7.1.5. Brazil Drug Discovery Outsourcing Market Revenue (US$ Mn) and
Forecasts, By End-users
17.7.1.5.1. Pharmaceutical
and Biotechnology companies
17.7.1.5.2. Academic
Institutes
17.7.1.5.3. Research
Organizations
17.7.1.5.4. Others
17.7.2. Argentina
17.7.2.1. Argentina Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Workflow
17.7.2.1.1. Target
Identification and Screening
17.7.2.1.2. Target
Validation and Functional Informatics
17.7.2.1.3. Lead
Optimization and Candidate Identification
17.7.2.1.4. Preclinical
Development
17.7.2.1.5. Others
17.7.2.2. Argentina Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Therapeutic Area
17.7.2.2.1. Respiratory
17.7.2.2.2. Pain
and Anesthesia
17.7.2.2.3. Oncology
17.7.2.2.4. Ophthalmology
17.7.2.2.5. Hematology
17.7.2.2.6. Cardiovascular
17.7.2.2.7. Endocrine
17.7.2.2.8. Gastrointestinal
17.7.2.2.9. Immunomodulation
17.7.2.2.10. Anti-infective
17.7.2.2.11. Central
Nervous System
17.7.2.2.12. Dermatology
17.7.2.2.13. Genitourinary
System
17.7.2.2.14. Others
17.7.2.3. Argentina Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Drug Type
17.7.2.3.1. Small
Molecules
17.7.2.3.2. Large
Molecules
17.7.2.4. Argentina Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By Service Type
17.7.2.4.1. Chemistry
Services
17.7.2.4.2. Biology
Services
17.7.2.5. Argentina Drug Discovery Outsourcing Market Revenue (US$ Mn)
and Forecasts, By End-users
17.7.2.5.1. Pharmaceutical
and Biotechnology companies
17.7.2.5.2. Academic
Institutes
17.7.2.5.3. Research
Organizations
17.7.2.5.4. Others
17.7.3. Rest of
Latin America
17.7.3.1. Rest of Latin America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Workflow
17.7.3.1.1. Target
Identification and Screening
17.7.3.1.2. Target
Validation and Functional Informatics
17.7.3.1.3. Lead
Optimization and Candidate Identification
17.7.3.1.4. Preclinical
Development
17.7.3.1.5. Others
17.7.3.2. Rest of Latin America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Therapeutic Area
17.7.3.2.1. Respiratory
17.7.3.2.2. Pain
and Anesthesia
17.7.3.2.3. Oncology
17.7.3.2.4. Ophthalmology
17.7.3.2.5. Hematology
17.7.3.2.6. Cardiovascular
17.7.3.2.7. Endocrine
17.7.3.2.8. Gastrointestinal
17.7.3.2.9. Immunomodulation
17.7.3.2.10. Anti-infective
17.7.3.2.11. Central
Nervous System
17.7.3.2.12. Dermatology
17.7.3.2.13. Genitourinary
System
17.7.3.2.14. Others
17.7.3.3. Rest of Latin America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By Drug Type
17.7.3.3.1. Small
Molecules
17.7.3.3.2. Large
Molecules
17.7.3.4. Rest of Latin America Drug Discovery Outsourcing Market Revenue
(US$ Mn) and Forecasts, By Service Type
17.7.3.4.1. Chemistry
Services
17.7.3.4.2. Biology
Services
17.7.3.5. Rest of Latin America Drug Discovery Outsourcing Market
Revenue (US$ Mn) and Forecasts, By End-users
17.7.3.5.1. Pharmaceutical
and Biotechnology companies
17.7.3.5.2. Academic
Institutes
17.7.3.5.3. Research
Organizations
17.7.3.5.4. Others
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Workflow
17.8.3. By
Therapeutic Area
17.8.4. By Drug
Type
17.8.5. By
Service Type
17.8.6. By
End-users
18. Competitive Benchmarking
18.1. Market
Share Analysis, 2022
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player Profiles
19.1. Charles
River Laboratories
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Domainex
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. Eurofins
DiscoverX Products
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. EVOTEC
SE
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. GenScript
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. Jubilant
Biosys Ltd
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. Laboratory
Corporation of America Holdings
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Oncodesign
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Pharmaron
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. QIAGEN
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Sygnature
Discovery
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business
Strategies
19.12. Syngene
International Ltd.
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key
Developments
19.12.5. Financial
Analysis
19.12.6. SWOT
Analysis
19.12.7. Business
Strategies
19.13. Thermo
Fisher Scientific Inc.
19.13.1. Company
Details
19.13.2. Company
Overview
19.13.3. Product
Offerings
19.13.4. Key
Developments
19.13.5. Financial
Analysis
19.13.6. SWOT
Analysis
19.13.7. Business
Strategies
19.14. WuXi
AppTec
19.14.1. Company
Details
19.14.2. Company
Overview
19.14.3. Product
Offerings
19.14.4. Key
Developments
19.14.5. Financial
Analysis
19.14.6. SWOT
Analysis
19.14.7. Business Strategies
19.15. Other
market participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
